US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatment
Brachytherapy, ISSN: 1538-4721, Vol: 23, Issue: 1, Page: 64-72
2024
- 5Citations
- 11Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- Captures11
- Readers11
- 11
- Mentions1
- News Mentions1
- 1
Most Recent News
Data on Radiotherapy Discussed by Researchers at University of Laval (Us-guided Em Tracked System for Hdr Brachytherapy: a First In-men Randomized Study for Whole Prostate Treatment)
2024 MAR 22 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Fresh data on Drugs and Therapies - Radiotherapy are
Article Description
An electromagnetic tracking device (EMT) has been integrated in an HDR 3D ultrasound guidance system for prostate HDR. The aim of this study was to compare the efficiency of HDR workflows with and without EM tracking. A total of 58 patients with a 15 Gy HDR prostate boost were randomized in two arms and two operation room (OR) procedures using: ( 1 ) the EMT investigational device, and ( 2 ) the Oncentra prostate system (OCP). OR times were compared for both techniques. The overall procedure median time was about 20% shorter for EMT (63 min) compared to OCP (79 min). The US acquisition and contouring was longer for OCP compared to EMT (23 min vs. 16 min). The catheter reconstruction's median times were 23 min and 13 min for OCP and EMT respectively. For the automatic reconstruction with EMT, 62% of cases required no or few manual corrections. Using the EM technology in an OR environment was challenging. In some cases, interferences or the stiffness of the stylet introduced errors in the reconstruction of catheters. The last step was the dosimetry with median times of 11 min (OCP) and 15.5 min (EMT). Finally, it was observed that there was no learning curve associated with the introduction of this new technology. The EMT device offers an efficient solution for automatic catheter reconstruction for HDR prostate while reducing the possibility of mis-reconstructed catheters caused by issues of visualization in the US images. Because of that, the overall OR times was shorter when using the EMT system.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1538472123016136; http://dx.doi.org/10.1016/j.brachy.2023.08.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85173250357&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37806788; https://linkinghub.elsevier.com/retrieve/pii/S1538472123016136; https://dx.doi.org/10.1016/j.brachy.2023.08.003
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know